Page last updated: 2024-10-25

clemizole and Astrocytoma, Grade IV

clemizole has been researched along with Astrocytoma, Grade IV in 1 studies

clemizole: was heading 1966-94 (see under BENZIMIDAZOLES 1966-90); use BENZIMIDAZOLES to search CLEMIZOLE 1966-94; a histamine H1- blocker used to treat allergies
clemizole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a pyrrolidin-1-ylmethyl and a 4-chlorobenzyl groups at positions 2 and 1 respectively.

Research Excerpts

ExcerptRelevanceReference
"Clemizole was not only effective in blocking heterologously expressed TRPC5 homomers but also TRPC1:TRPC5 heteromers as well as native TRPC5-like currents in the U-87 glioblastoma cell line."1.40Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5. ( Hill, K; Richter, JM; Schaefer, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richter, JM1
Schaefer, M1
Hill, K1

Other Studies

1 other study available for clemizole and Astrocytoma, Grade IV

ArticleYear
Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5.
    Molecular pharmacology, 2014, Volume: 86, Issue:5

    Topics: Benzimidazoles; Calcium; Cell Line, Tumor; Cell Membrane; Glioblastoma; HEK293 Cells; Humans; Patch-

2014